Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.560ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.560ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.560ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.560NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.610ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.610ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.610ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.610NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
AY.10 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.10 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.10 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.10 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.286ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.286ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.286ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.286NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.369ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.369ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.369ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.369NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.69ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.69NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used